Emgrast M 500mcg Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections.

Emgrast M 500mcg Injection is used to treat abnormally low levels of a kind of white blood cells (neutrophils) in the body due to various causes

Uses of Emgrast M Injection

Prevention of Infections after chemotherapy

Benefits of Emgrast M Injection

In Prevention of Infections after chemotherapy

Emgrast M 500mcg Injection increases the production of white blood cells by stimulating the immune system in our body. White blood cells are those cells that help us to fight infections. This medicine is really effective and must be used under medical supervision. Avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to.

Side effects of Emgrast M Injection

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Emgrast M

Bone pain
Decreased blood pressure
Fever
Breathlessness
Feeling of discomfort
Vomiting
Flushing (sense of warmth in the face, ears, neck and trunk)
Nausea
Flu-like symptoms
Rash
Diarrhea

How to use Emgrast M Injection

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Safety advice

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Emgrast M 500mcg Injection. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

Emgrast M 500mcg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

SAFE IF PRESCRIBED

Emgrast M 500mcg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Driving

CONSULT YOUR DOCTOR

It is not known whether Emgrast M 500mcg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Kidney

CAUTION

Emgrast M 500mcg Injection should be used with caution in patients with kidney disease. Dose adjustment of Emgrast M 500mcg Injection may be needed. Please consult your doctor.
Regular monitoring of kidney function tests is advised while you are taking this medicine.

Liver

CAUTION

Emgrast M 500mcg Injection should be used with caution in patients with liver disease. Dose adjustment of Emgrast M 500mcg Injection may be needed. Please consult your doctor.
Regular monitoring of liver function tests is advised while you are taking this medicine.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

No substitutes found for this medicine

Quick tips

Emgrast M 500mcg Injection is given as an injection into a vein or under the skin by the healthcare provider only.
Do not skip any dose and complete the course as suggested by your doctor.
Use an effective method of birth control to avoid pregnancy while taking this medication.
Your doctor may get regular blood tests done to monitor your blood cell count and liver function.
Inform your doctor if you experience fever, chills, sore throat and shortness of breath during the treatment.

Fact Box

Chemical Class

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)

Habit Forming

Therapeutic Class

ANTI NEOPLASTICS

Action Class

Granulocyte-macrophage colony stimulating factor (GM-CSF)

Patient concerns

Plz check the report and reply She is my wife report one of hospital where operated the tumot operation and one of from delhi srl and last one from tmh mumbai After the diagnosis docror advice rediation now 1 st rediation therapy is finished and doctor giving now nublast 250mg tab So plz check the report and tell me as per the tata memorial final report what is the condition for patient She can live normal life or she can dead in ahead Doctor tells with my family she can live with treatment more than 1 to 2 years Is it right or wrong

Dr. Vijay Sharnangat

Medical Oncology and Hematology

You are on right treatmentAfter completion of radiation therapy you need to take chemotherapyThat tablet is the chemotherapy

What is symptomatic after chemotherapy for metastatic spine

Dr. Vijay Sharnangat

Medical Oncology and Hematology

Back pain is main symptom which you can get after disease progression

What would be the best treatment for this disease. As i am very confused about doctor's advice. Some said to start chemo 6 cycles without even pet scan. Doctor from hcg Bangalore advised for radiation for 28 set. But doctor's from Bangalore Baptist hospital advised for 3 cycle of chemo therapy finally i did the pet scan and tomorrow have a appointment with the doctor from Baptist hospital.

Dr. Vijay Sharnangat

Medical Oncology and Hematology

Ideal treatment for these tumor would be chemotherapy along with radiation therapy, but your patient has fistula after surgery so radiation would not be possible, so ahead with chemotherapy. You can have 4 to 6 cycles.

User feedback

Patients taking Emgrast M 500mcg Injection

Once A Month

43%

Once A Day

29%

Alternate Day

14%

Twice A Week

14%

What are you using Emgrast M Injection for?

Infection pre*

50%

Others

50%

*Infection prevention for chemotherapy

Related lab tests

Complete Blood Count

Peripheral Smear Examination

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Masters SB. Agents Used in Anemias; Hematopoetic Growth Factors. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 581-82.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1247-48.
Hematopoietic Agents: Growth Factors, Minerals, and Vitamins. In: Hilal-Dandan R, Brunton LL, editors. Goodman and Gilman's Manual of Pharmacology and Therapeutics. 2nd ed. New York, New York: The McGraw-Hill Companies, Inc.; 2014. [Accessed 30 Jan. 2019] (online) Available from:
Drugs.com. Sargramostim Pregnancy and Breastfeeding Warnings. [Accessed 27 Mar. 2019] (online) Available from:

Marketer details

Name: Emcure Pharmaceuticals Ltd

Address: 255/2, Hinjawadi, Pune - 411057, India

Country of origin: India

220 people viewed this recently

MRP

₹3259

Inclusive of all taxes

1.0 Injection in 1 vial

SOLD OUT

Notify me

We provide you with authentic, trustworthy and relevant information

Have issue with the content?

Emgrast M 500mcg Injection

Product introduction

Uses of Emgrast M Injection

Benefits of Emgrast M Injection

In Prevention of Infections after chemotherapy

Side effects of Emgrast M Injection

Common side effects of Emgrast M

How to use Emgrast M Injection

Safety advice

All substitutes

Quick tips

Fact Box

Patient concerns

User feedback

Want to share the information?

Disclaimer:

References

Marketer details

Lab tests offered by us